Stay updated on Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Immunotherapy in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on non-small cell lung cancer, while adding a new revision number and collaborators.SummaryDifference15%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page has been updated to reflect a new last update date of March 30, 2025, and a revision change to version 2.14.3. Additionally, the name 'Millennium Oncology' has been added.SummaryDifference0.9%
- Check59 days agoChange DetectedThe webpage has updated its date references, removing older dates and adding new ones for March and August 2025.SummaryDifference0.6%
- Check66 days agoChange DetectedThe page has updated the number of study locations from 45 to 48 and added specific locations in Maryland, Nevada, and South Carolina.SummaryDifference2%
Stay in the know with updates to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in NSCLC Clinical Trial page.